US 12285425
Glucocorticoid receptor modulators to treat cervical cancer
granted A61KA61K31/337A61K31/4745
Quick answer
US patent 12285425 (Glucocorticoid receptor modulators to treat cervical cancer) held by Corcept Therapeutics Incorporated expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/337, A61K31/4745, A61P, A61P35/00